<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30196260</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1757-790X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>2018</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>08</Day>                    </PubDate>                </JournalIssue>                <Title>BMJ case reports</Title>                <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Long-term survival in a patient with pulmonary spindle cell carcinoma treated with traditional Chinese medicine.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">bcr-2018-225989</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2018-225989</ELocationID>            <Abstract>                <AbstractText>Spindle cell carcinoma (SCC) is a rare pulmonary malignancy, accounting for only 0.2%-0.3% of all lung cancers. Therefore, the prognosis and treatment of pulmonary SCC is unclear. There are only 13 reported cases in literature, only three of which had a survival of more than 11 months. Here we reported a long-term survival of a patient with pulmonary SCC who underwent treatment with traditional Chinese medicine. At the most recent follow-up in July 2018, her survival after diagnosis is 48 months and she continues to do well. To our knowledge, this is the longest survival of late stage SCC with the largest tumour burden.</AbstractText>                <CopyrightInformation>Â© BMJ Publishing Group Limited 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Wenyuan</ForeName>                    <Initials>W</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8831-9889</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Tianjin Tumor Hospital, Tianjin, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Maoyan</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhao</LastName>                    <ForeName>Yuanhong</ForeName>                    <Initials>Y</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0562-5718</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>08</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMJ Case Rep</MedlineTA>            <NlmUniqueID>101526291</NlmUniqueID>            <ISSNLinking>1757-790X</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Apr 7;8(34):56351-56363</RefSource>                <PMID Version="1">28915595</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2018 Feb 12;2018:6517034</RefSource>                <PMID Version="1">29619072</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2016 Mar 29;17(4):465</RefSource>                <PMID Version="1">27043533</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Case Rep. 2015 Nov 12;16:805-10</RefSource>                <PMID Version="1">26558362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Drugs. 2015 Jul;26(6):649-56</RefSource>                <PMID Version="1">25811965</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Jun;96(24):e7129</RefSource>                <PMID Version="1">28614235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phytother Res. 2012 Jun;26(6):915-25</RefSource>                <PMID Version="1">22105892</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Pathol. 2007 May;60(5):472-5</RefSource>                <PMID Version="1">16731596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Complement Altern Med. 2016 Nov 10;16(1):456</RefSource>                <PMID Version="1">27832784</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Microcirculation. 2014 Oct;21(7):649-63</RefSource>                <PMID Version="1">24809727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2017 Dec;14(6):8197-8205</RefSource>                <PMID Version="1">29344262</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2013;2013:153148</RefSource>                <PMID Version="1">23983772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Drug Dev Res. 2016 Mar;77(2):73-86</RefSource>                <PMID Version="1">26971531</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Chin Med. 2017;45(2):225-238</RefSource>                <PMID Version="1">28231744</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacol Sci. 2005 Jul;98(3):327-30</RefSource>                <PMID Version="1">16006736</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Natl Health Stat Report. 2009 Jul 30;(18):1-14</RefSource>                <PMID Version="1">19771719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Res Int. 2016;2016:1490738</RefSource>                <PMID Version="1">27042656</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med Rep. 2017 Dec;16(6):8729-8734</RefSource>                <PMID Version="1">29039573</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2015 Sep;10(3):1240-1250</RefSource>                <PMID Version="1">26622657</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Hepatol. 2015 May 28;7(9):1209-32</RefSource>                <PMID Version="1">26019736</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Ethnopharmacol. 2008 Mar 5;116(2):207-10</RefSource>                <PMID Version="1">18243610</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chest. 2000 Feb;117(2):591-3</RefSource>                <PMID Version="1">10669709</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>ScientificWorldJournal. 2013 Nov 14;2013:896873</RefSource>                <PMID Version="1">24348193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>OMICS. 2016 Nov;20(11):670-680</RefSource>                <PMID Version="1">27732148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Sci Monit. 2018 Apr 10;24:2126-2133</RefSource>                <PMID Version="1">29632297</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Dec 08;9(12):e113887</RefSource>                <PMID Version="1">25485843</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chin Med. 2016 May 31;11:27</RefSource>                <PMID Version="1">27252774</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jun 27;8(26):43228-43236</RefSource>                <PMID Version="1">28591732</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nihon Kokyuki Gakkai Zasshi. 2009 Sep;47(9):828-32</RefSource>                <PMID Version="1">19827589</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2015 May 07;34:41</RefSource>                <PMID Version="1">25948105</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">cancer intervention</Keyword>            <Keyword MajorTopicYN="N">complementary medicine</Keyword>            <Keyword MajorTopicYN="N">lung cancer (oncology)</Keyword>        </KeywordList>        <CoiStatement>Competing interests: None declared.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30196260</ArticleId>            <ArticleId IdType="pii">bcr-2018-225989</ArticleId>            <ArticleId IdType="doi">10.1136/bcr-2018-225989</ArticleId>            <ArticleId IdType="pmc">PMC6129063</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>